In vivo response to high-resolution variation of Tbx1 mRNA dosage
about
The neural crest in cardiac congenital anomaliesMutations in SIPA1L3 cause eye defects through disruption of cell polarity and cytoskeleton organizationMouse TBX3 mutants suggest novel molecular mechanisms for Ulnar-mammary syndromeHes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndromePartial rescue of the Tbx1 mutant heart phenotype by Fgf8: genetic evidence of impaired tissue response to Fgf8Lethal arrhythmias in Tbx3-deficient mice reveal extreme dosage sensitivity of cardiac conduction system function and homeostasisBmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanismA novel role for transcription factor Lmo4 in thymus development through genetic interaction with Cited2Tbx1 controls cardiac neural crest cell migration during arch artery development by regulating Gbx2 expression in the pharyngeal ectodermA Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesisMOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndromeEnamel-free teeth: Tbx1 deletion affects amelogenesis in rodent incisorsSchizophrenia and 22q11.2 deletion syndrome.Chordin is a modifier of tbx1 for the craniofacial malformations of 22q11 deletion syndrome phenotypes in mouse.Tbx1 modulates endodermal and mesodermal differentiation from mouse induced pluripotent stem cells.Decreased levels of embryonic retinoic acid synthesis accelerate recovery from arterial growth delay in a mouse model of DiGeorge syndromeDetecting 22q11.2 deletion in Chinese children with conotruncal heart defects and single nucleotide polymorphisms in the haploid TBX1 locus.p53 Suppression partially rescues the mutant phenotype in mouse models of DiGeorge syndrome.Phenotypic impact of genomic structural variation: insights from and for human disease.Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disordersNK4 antagonizes Tbx1/10 to promote cardiac versus pharyngeal muscle fate in the ascidian second heart fieldMutations in MAB21L2 result in ocular Coloboma, microcornea and cataractsTBX1 protein interactions and microRNA-96-5p regulation controls cell proliferation during craniofacial and dental development: implications for 22q11.2 deletion syndrome.Complex congenital heart disease in unaffected relatives of adults with 22q11.2 deletion syndromeGenotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.EFTUD2 deficiency in vertebrates: Identification of a novel human mutation and generation of a zebrafish model.Tbx1 is a negative modulator of Mef2c.Pharyngeal mesoderm regulatory network controls cardiac and head muscle morphogenesisRebalancing gene haploinsufficiency in vivo by targeting chromatin.22q11.2 deletion syndromeCopy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndromeA 3 base pair deletion in TBX1 leads to reduced protein expression and transcriptional activity.Tbx1, subpulmonary myocardium and conotruncal congenital heart defects.Implications of COMT long-range interactions on the phenotypic variability of 22q11.2 deletion syndrome.Increased Tbx1 expression may play a role via TGFβ-Smad2/3 signaling pathway in acute kidney injury induced by gentamicinBiallelic expression of Tbx1 protects the embryo from developmental defects caused by increased receptor tyrosine kinase signaling.SDF1-CXCR4 signaling: A new player involved in DiGeorge/22q11-deletion syndrome.Vitamin B12 ameliorates the phenotype of a mouse model of DiGeorge syndrome.Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants.
P2860
Q27024385-C093F0B9-89A6-4C33-8081-B6C8344713AAQ28118377-CF20A51A-B3E8-44C4-B856-251954D2A8C5Q28510805-ABCAA351-C7C5-4978-82B0-59DA3D18347EQ28513290-2BC68039-1FD7-46A2-89BA-19653E79EF0BQ28585923-AC4A8745-970F-4679-8AF9-A05F82A446E2Q28586231-8A05D250-07BF-4EE8-AFEB-6E27EB50FC81Q28586556-AEE945F4-CE29-4EE0-A7D0-3445614F5EE0Q28587320-61BEB91A-95AB-4145-AFA7-25FBA81CF682Q28588434-F342E638-9FD6-4ED5-96AC-93371EB9E51EQ28589314-5529A0FF-77CE-4815-9B6B-1FF8321B8880Q28592234-BDCB08E6-BE32-4EBF-8120-99CF20678210Q28593230-F469DFF6-477B-4B06-90E9-77A80D375F43Q31155236-A9FE818C-242C-4951-A5F6-B9D893816BF8Q33413046-EDDDE6FB-1139-4827-85DE-EC9E78D5550DQ33788869-5585C7B8-62FC-4AC1-B4E9-72DF04D4EF9CQ33829670-14918413-3611-4B61-B1B4-6685AC3D0C15Q34106724-6EF3A7B9-F200-4F6E-9C92-B962F223493BQ34218341-7A61184A-4D26-4002-B944-61CC20CEBE21Q34323221-C58850DD-042D-42F7-833C-7489B15F9987Q34355317-9DA49069-A246-4212-8987-62E9D8F02164Q35060118-F8346631-816C-4516-BCF4-2628991DDD31Q35125578-15AD01F2-64EA-4459-A042-80817929FE1CQ35234113-FA4C6F4C-F292-478F-BA18-4B5FC32CD10FQ35281043-ABDD8D57-CCD5-49FF-8047-BD7C2DD35A86Q35388414-F6CC77AA-5E37-4964-8CEC-C809674FE191Q35805964-9864A05F-FD19-4799-84E1-E814B7E5AABAQ35950440-7A411273-BA5F-4A0F-A8D8-C05CE114FA5DQ36414768-48A0BD47-7EA8-4331-8004-5DC026F9AB07Q36975915-AE1EB80B-E035-4321-A316-B1EBA3EB1C8DQ36988231-41E0A611-E442-47A2-A32F-523CB4DF6C7CQ37089619-6D190B59-8CD4-4605-987B-261545B03037Q37341674-CDDAFE40-9526-4E10-978F-60126E835C94Q37685976-1E1D6E54-E445-4EEF-909E-3A1684E02966Q37876851-4363D340-F847-49A6-8690-3FAC850DC408Q39032176-D0EFFE8F-3D44-4241-A213-64878BAF194BQ39378558-7C0059C7-D6FD-4A86-8FBC-2129FFFD9B08Q40416047-06179850-89D4-4950-B808-CFA14C1CE87DQ41901850-82133F94-A92B-4861-89C7-A68F38A548BFQ41907176-98FEA17B-0D63-4FA5-BD26-4574A0C46495Q41910576-8C6CF40E-8741-4C9A-8074-94BA3AD8EC20
P2860
In vivo response to high-resolution variation of Tbx1 mRNA dosage
description
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Januar 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/01/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/01/01)
@nl
наукова стаття, опублікована в січні 2008
@uk
مقالة علمية (نشرت عام 2008)
@ar
name
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@ast
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@en
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@nl
type
label
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@ast
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@en
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@nl
prefLabel
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@ast
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@en
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@nl
P3181
P356
P1476
In vivo response to high-resolution variation of Tbx1 mRNA dosage
@en
P2093
Antonio Baldini
P304
P3181
P356
10.1093/HMG/DDM291
P50
P577
2007-10-04T00:00:00Z